BACKGROUND Prostate specific membrane antigen (PSM) is a membrane‐bound antigen
that is highly specific for benign and malignant prostate epithelial cells. Its expression in high …

Objectives. Prostate-specific membrane antigen (PSMA) is an integral membrane protein
highly specific for the prostate. PSMA may be clinically useful for predicting outcome in patients …

Objectives. We describe the expression of a potentially new tumor marker, human glandular
kallikrein 2 (hK2), that may be useful as an adjunct to prostate-specific antigen (PSA) in the …

High‐grade PIN is the most likely precursor of prostatic adenocarcinoma, according to virtually
all available evidence to date. The clinical importance of recognizing PIN is based on its …

BACKGROUND Extraprostatic extension (EPE) is an unfavorable prognostic factor in patients
with prostate carcinoma. Prior studies have reported the linear extent of EPE measured …

OBJECTIVES: Intestinal metaplasia often coexists with adenocarcinoma of the urinary bladder,
suggesting to some investigators that it is premalignant. However, the natural history and …

Objectives. To describe the expression of a potential new tumor marker, human glandular
kallikrein 2 (hK2), in primary adenocarcinoma and lymph node metastases that may be useful …

Positron emission tomography (PET) is a diagnostic nuclear imaging modality that relies on
automated protocols to prepare agents labeled with a positron-emitting radionuclide (eg, 18 …

Purpose : Neuroendocrine cells are ubiquitous but uncommon in benign and neoplastic
prostate epithelium, and they are considered important for regulating cell growth and …

Nine patients treated with primary signet ring cell carcinoma of the prostate were identified
among 29,783 cases of prostate cancer evaluated at Mayo Clinic from January 15, 1970, until …